{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T19:27:44Z","timestamp":1769282864244,"version":"3.49.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2007,9,15]],"date-time":"2007-09-15T00:00:00Z","timestamp":1189814400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1186\/1471-2369-8-13","type":"journal-article","created":{"date-parts":[[2007,9,15]],"date-time":"2007-09-15T18:13:16Z","timestamp":1189879996000},"source":"Crossref","is-referenced-by-count":43,"title":["Clinical proof-of-concept trial to assess the therapeutic effect of sirolimus in patients with autosomal dominant polycystic kidney disease: SUISSE ADPKD study"],"prefix":"10.1186","volume":"8","author":[{"given":"Andreas L","family":"Serra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas D","family":"Kistler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diane","family":"Poster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marian","family":"Struker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rudolf P","family":"W\u00fcthrich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominik","family":"Weishaupt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank","family":"Tschirch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,9,15]]},"reference":[{"key":"89_CR1","first-page":"1","volume":"328","author":"OZ Dalgaard","year":"1957","unstructured":"Dalgaard OZ: Bilateral polycystic disease of the kidneys; a follow-up of two hundred and eighty-four patients and their families. Acta Med Scand Suppl. 1957, 328: 1-255.","journal-title":"Acta Med Scand Suppl"},{"issue":"9147","key":"89_CR2","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/S0140-6736(98)03495-3","volume":"353","author":"N Hateboer","year":"1999","unstructured":"Hateboer N, v Dijk MA, Bogdanova N, Coto E, Saggar-Malik AK, San Millan JL, Torra R, Breuning M, Ravine D: Comparison of phenotypes of polycystic kidney disease types 1 and 2. European PKD1-PKD2 Study Group. Lancet. 1999, 353 (9147): 103-107. 10.1016\/S0140-6736(98)03495-3.","journal-title":"Lancet"},{"issue":"2","key":"89_CR3","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1056\/NEJMra022161","volume":"350","author":"PD Wilson","year":"2004","unstructured":"Wilson PD: Polycystic kidney disease. N Engl J Med. 2004, 350 (2): 151-164. 10.1056\/NEJMra022161.","journal-title":"N Engl J Med"},{"issue":"2","key":"89_CR4","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.ymgme.2003.10.010","volume":"81","author":"PC Harris","year":"2004","unstructured":"Harris PC, Rossetti S: Molecular genetics of autosomal recessive polycystic kidney disease. Mol Genet Metab. 2004, 81 (2): 75-85. 10.1016\/j.ymgme.2003.10.010.","journal-title":"Mol Genet Metab"},{"issue":"10","key":"89_CR5","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1681\/ASN.V7102142","volume":"7","author":"R Torra","year":"1996","unstructured":"Torra R, Badenas C, Darnell A, Nicolau C, Volpini V, Revert L, Estivill X: Linkage, clinical features, and prognosis of autosomal dominant polycystic kidney disease types 1 and 2. J Am Soc Nephrol. 1996, 7 (10): 2142-2151.","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"89_CR6","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1038\/ki.1983.51","volume":"23","author":"KA Franz","year":"1983","unstructured":"Franz KA, Reubi FC: Rate of functional deterioration in polycystic kidney disease. Kidney Int. 1983, 23 (3): 526-529. 10.1038\/ki.1983.51.","journal-title":"Kidney Int"},{"issue":"20","key":"89_CR7","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.1056\/NEJMoa054341","volume":"354","author":"JJ Grantham","year":"2006","unstructured":"Grantham JJ, Torres VE, Chapman AB, Guay-Woodford LM, Bae KT, King BF, Wetzel LH, Baumgarten DA, Kenney PJ, Harris PC, Klahr S, Bennett WM, Hirschman GN, Meyers CM, Zhang X, Zhu F, Miller JP: Volume progression in polycystic kidney disease. N Engl J Med. 2006, 354 (20): 2122-2130. 10.1056\/NEJMoa054341.","journal-title":"N Engl J Med"},{"issue":"2","key":"89_CR8","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/BF02927815","volume":"3","author":"HS Thomsen","year":"1981","unstructured":"Thomsen HS, Madsen JK, Thaysen JH, Damgaard-Petersen K: Volume of polycystic kidneys during reduction of renal function. Urol Radiol. 1981, 3 (2): 85-89.","journal-title":"Urol Radiol"},{"issue":"1","key":"89_CR9","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1111\/j.1523-1755.2005.00395.x","volume":"68","author":"P Ruggenenti","year":"2005","unstructured":"Ruggenenti P, Remuzzi A, Ondei P, Fasolini G, Antiga L, Ene-Iordache B, Remuzzi G, Epstein FH: Safety and efficacy of long-acting somatostatin treatment in autosomal-dominant polycystic kidney disease. Kidney Int. 2005, 68 (1): 206-216. 10.1111\/j.1523-1755.2005.00395.x.","journal-title":"Kidney Int"},{"issue":"23","key":"89_CR10","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1056\/NEJMoa012843","volume":"346","author":"MC Morice","year":"2002","unstructured":"Morice MC, Serruys PW, Sousa JE, Fajadet J, Ban Hayashi E, Perin M, Colombo A, Schuler G, Barragan P, Guagliumi G, Molnar F, Falotico R: A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med. 2002, 346 (23): 1773-1780. 10.1056\/NEJMoa012843.","journal-title":"N Engl J Med"},{"issue":"13","key":"89_CR11","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1056\/NEJMoa042831","volume":"352","author":"G Stallone","year":"2005","unstructured":"Stallone G, Schena A, Infante B, Di Paolo S, Loverre A, Maggio G, Ranieri E, Gesualdo L, Schena FP, Grandaliano G: Sirolimus for Kaposi's sarcoma in renal-transplant recipients. N Engl J Med. 2005, 352 (13): 1317-1323. 10.1056\/NEJMoa042831.","journal-title":"N Engl J Med"},{"issue":"3","key":"89_CR12","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1093\/ndt\/gfi181","volume":"21","author":"PR Wahl","year":"2006","unstructured":"Wahl PR, Serra AL, Le Hir M, Molle KD, Hall MN, Wuthrich RP: Inhibition of mTOR with sirolimus slows disease progression in Han:SPRD rats with autosomal dominant polycystic kidney disease (ADPKD). Nephrol Dial Transplant. 2006, 21 (3): 598-604. 10.1093\/ndt\/gfi181.","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"89_CR13","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1159\/000104818","volume":"30","author":"M Wu","year":"2007","unstructured":"Wu M, Wahl PR, Le Hir M, Waeckerle-Men Y, Wuthrich RP, Serra AL: Everolimus retards cyst growth and preserves kidney function in a rodent model for polycystic kidney disease . Kidney Blood Press Res. 2007, 30 (4): 253-259. 10.1159\/000104818.","journal-title":"Kidney Blood Press Res"},{"issue":"1","key":"89_CR14","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1681\/ASN.2004080660","volume":"16","author":"Y Tao","year":"2005","unstructured":"Tao Y, Kim J, Schrier RW, Edelstein CL: Rapamycin markedly slows disease progression in a rat model of polycystic kidney disease. J Am Soc Nephrol. 2005, 16 (1): 46-51. 10.1681\/ASN.2004080660.","journal-title":"J Am Soc Nephrol"},{"issue":"14","key":"89_CR15","doi-asserted-by":"publisher","first-page":"5466","DOI":"10.1073\/pnas.0509694103","volume":"103","author":"JM Shillingford","year":"2006","unstructured":"Shillingford JM, Murcia NS, Larson CH, Low SH, Hedgepeth R, Brown N, Flask CA, Novick AC, Goldfarb DA, Kramer-Zucker A, Walz G, Piontek KB, Germino GG, Weimbs T: From the Cover: The mTOR pathway is regulated by polycystin-1, and its inhibition reverses renal cystogenesis in polycystic kidney disease. Proc Natl Acad Sci U S A. 2006, 103 (14): 5466-5471. 10.1073\/pnas.0509694103.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"89_CR16","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1016\/S0149-2918(99)80026-5","volume":"21","author":"KC Farmer","year":"1999","unstructured":"Farmer KC: Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice. Clin Ther. 1999, 21 (6): 1074-90; discussion 1073. 10.1016\/S0149-2918(99)80026-5.","journal-title":"Clin Ther"},{"issue":"5","key":"89_CR17","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1056\/NEJMra050100","volume":"353","author":"L Osterberg","year":"2005","unstructured":"Osterberg L, Blaschke T: Adherence to medication. N Engl J Med. 2005, 353 (5): 487-497. 10.1056\/NEJMra050100.","journal-title":"N Engl J Med"},{"key":"89_CR18","unstructured":"SUISSE ADPKD Study . [ http:\/\/www.ADPKD.ch ]"},{"issue":"8901","key":"89_CR19","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/S0140-6736(94)92026-5","volume":"343","author":"D Ravine","year":"1994","unstructured":"Ravine D, Gibson RN, Walker RG, Sheffield LJ, Kincaid-Smith P, Danks DM: Evaluation of ultrasonographic diagnostic criteria for autosomal dominant polycystic kidney disease 1. Lancet. 1994, 343 (8901): 824-827. 10.1016\/S0140-6736(94)92026-5.","journal-title":"Lancet"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2369-8-13\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2369-8-13.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2369-8-13","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2369-8-13.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,23]],"date-time":"2021-08-23T13:38:19Z","timestamp":1629725899000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/1471-2369-8-13"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9,15]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["89"],"URL":"https:\/\/doi.org\/10.1186\/1471-2369-8-13","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,9,15]]},"article-number":"13"}}